In: International Journal of Public Health, 2015, vol. 60, no. 8, p. 873-875
|
In: International Journal of Public Health, 2020, vol. 65, no. 9, p. 1529–1548
Objectives Seroprevalence studies to assess the spread of SARS-CoV-2 infection in the general population and subgroups are key for evaluating mitigation and vaccination policies and for understanding the spread of the disease both on the national level and for comparison with the international community. Methods Corona Immunitas is a research program of coordinated, population-based,...
|
In: Nonprofit Policy Forum, 2016, vol. 7, no. 4, p. 509-539
|
In: Nucleic Acids Research, 2014, vol. 42, no. 1, p. 609-621
|
Thèse de doctorat : Università della Svizzera italiana, 2015 ; 2015ECO003.
Switzerland is a country with a strongly decentralized political system, based on federalism and institutions of direct democracy, on a liberal economic culture, and on a well-developed tradition of mutualism and social security (generous social expenditure and welfare system). Switzerland is unique for its high level of decentralization and for the particular distribution of competences and...
|
In: Health policy, 2013, vol. 109, no. 2, p. 105-112
This article addresses three topics. First, it reports on the international interest in the health care reforms of Switzerland and The Netherlands in the 1990s and early 2000s that operate under the label “managed competition” or “consumer-driven health care.” Second, the article reviews the behavior assumptions that make plausible the case for the model of “managed competition.”...
|
In: Health policy, 2012, vol. 106, no. 1, p. 37-49
This paper explores leadership and governance arrangements in seven developed health systems: Australia, England, Germany, the Netherlands, Norway, Sweden and Switzerland. It presents a cybernetic model of leadership and governance comprising three fundamental functions: priority setting, performance monitoring and accountability arrangements. The paper uses a structured survey to examine...
|
In: Health policy, 2013, vol. 109, no. 3, p. 209-225
This article considers the potential for insurer competition to improve health system performance by strengthening purchasing. Economic theory suggests that insurer competition will enhance efficiency if: (1) people have free choice of insurer, (2) competition is based on price and quality rather than risk selection and (3) insurers have tools to influence health care costs and quality. The...
|
Previous studies have viewed Swiss health-care financing as particularly regressive. However, as the OECD Review of the Swiss Health System (2011) stated, the income-related inequities and the inter cantonal variations are still unexplored due to a lack of available information. The present paper aims to fill this information gap concerning the Swiss health system by exploring the...
|
In: Revue française des affaires sociales, 2006, vol. 60, no. 2-3, p. 239-262
Le système suisse d’assurance maladie se situe à mi-chemin entre une assurance sociale et une assurance privée. L'assurance est obligatoire et gérée par une pluralité de caisses maladies privées sans but lucratif, qui sont formellement en concurrence et offrant un panier identique de prestations. La prime de l’assurance est indépendante du revenu et varie en fonction du canton de...
|